The Patent Finder

Caregen Co., Ltd.

67 patents currently held · Updated Nov 15, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
8
Ending by 2030
Mar 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 13, 2026
    The maintenance fee for Peptide Exhibiting Wrinkle-Improving Activity and Uses Thereof (US 11,672,749) comes due Dec 13, 2026. Unpaid by Jun 14, 2027, it lapses early.
  • 3 fees due Jan 9 to 16, 2027 · next Jan 9
  • 1 fee due May 26, 2027
    The maintenance fee for Peptide having activity to improve skin condition and use thereof (US 10,487,113) comes due May 26, 2027. Unpaid by Nov 26, 2027, it lapses early.
  • 1 fee due Jun 17, 2027
    The maintenance fee for Peptide Having Hair Growth-Promoting Activity And/Or Melanin Generation-Promoting Activity, and Use Thereof (US 10,508,140) comes due Jun 17, 2027. Unpaid by Dec 17, 2027, it lapses early.
  • 2 fees due Jul 2 to 7, 2027 · next Jul 2
  • 1 fee due Aug 25, 2027
    The maintenance fee for Peptide having hair growth-promoting activity and use thereof (US 10,568,828) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.
  • 1 fee due Sep 29, 2027
    The maintenance fee for WNT family-derived peptides and use thereof (US 9,295,629) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
  • 2 fees due Oct 5 to 21, 2027 · next Oct 5

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 17, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 8,263,095Methods of use for peptides having activities of insulin like growth factor-1
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,939,495Method for improving skin conditions
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,106,017Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,188,049Peptides having activities of epidermal growth factor and its uses
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,691,195Peptide having activity of transforming growth factor and production method therefor
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,497,241WNT10-derived peptide and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,729,028Noggin-derived peptide and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,501,689Growth factor-mimicking peptides and uses thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,969,296Tgfp-Cap Peptide and Its Uses
In force
 · High confidence
In forceHigh confidence
US 9,303,064Peptide inhibiting matrix metalloproteanases activity and use thereof
In force
 · From the USPTO record
In forceFrom the USPTO record
10 of 67 patents shown.
Pro members see all 67.
Pro members: see all 67 patents

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

23 pending · 2 abandoned · 3 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited